Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Drug Manufacturers - Major Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > QIXLEEF and ENJOUCA
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(328)
•••
Post by Golddetectoron Nov 19, 2021 7:12am
254 Views
Post# 34144483

QIXLEEF and ENJOUCA

QIXLEEF and ENJOUCAEinstein, for QIXLEEF to be sold as prescription drug it has to complete all trial phases. However, guy mentioned in one of his videos that there is a specific procedure were patient can request that. It is limited though imo. However, tetra has subsidiary enjouca that is going to market QIXLEEF based on these results in other jurisdictions where cannabis is legal like Canada but not as prescription drug. Let's keep in mind that the drug completed fda phase I trial successfully and worth 250 millions at least at end of phase ii the drug will worth billion at least. You have seen how Pfizer paid for trillium yesterday which very similar stage. Below a link to video from Guy back in feb talking about ENJOUCA

 https://youtu.be/WOKK5A9or9s
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities